Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Free Flap Transfer, Malignant Neoplasm
Interventions: EchoMark, EchoSure; Device
Lead sponsor: Sonavex, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 14 participants
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cryptogenic Symptomatic Transient Ischemic Attack, Cryptogenic Ischemic Stroke
Interventions: Reveal® XT Insertable Cardiac Monitor; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 40 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 19
States / cities: Mountain View, California • Denver, Colorado • Chicago, Illinois + 15 more

Conditions: LVAD, Frailty, GI Bleed, Right Heart Failure, Infections, Hypertension, Arrhythmias, Stroke
Interventions: HeartMate 3 (R) left ventricular assist device; Device
Lead sponsor: International Consortium of Circulatory Assist Clinicians; Other
Eligibility: 18 Years to 100 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: San Francisco, California • Gainesville, Florida • Chicago, Illinois + 4 more

Conditions: Bilateral Cochlear Aplasia, Bilateral Cochlear Nerve Deficiency, Bilateral Cochlear Ossification Secondary to Meningitis
Interventions: Auditory brainstem implant; Device
Lead sponsor: House Research Institute; Other
Eligibility: 2 Years to 5 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Burns
Interventions: Biodegradable Temporizing Matrix; Device
Lead sponsor: PolyNovo Biomaterials Pty Ltd.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 5
States / cities: Phoenix, Arizona • Sacramento, California • Tampa, Florida + 2 more

Conditions: Parkinson Disease, Essential Tremor, Multiple Sclerosis, Dystonia
Interventions: Therapeutic Stimulation Patterns, Symptogenic Stimulation Patterns; Procedure
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 3
States / cities: Gainesville, Florida • Atlanta, Georgia • Durham, North Carolina

Conditions: Shoulder Pain, Shoulder Injuries, Shoulder Fractures, Shoulder Disease, Shoulder Arthritis
Interventions: Comprehensive Primary Revision Stems; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2040
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pulpal Necrosis
Interventions: Left Tooth Platelet Rich Fibrin; Right Tooth Implant Alone, Right Tooth Platelet Rich Fibrin; Left Tooth Implant Alone; Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Bradycardia
Interventions: Evaluation Group, Control Group (Historical); Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 257 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 11
States / cities: Palo Alto, California • Hartford, Connecticut • Daytona Beach, Florida + 8 more

Conditions: Diabetic Wounds, Venous Stasis Wounds
Interventions: injection of lipoaspirate, control; Procedure · Other
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 20 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Degenerative Lumbar Spinal Stenosis
Interventions: Single-Level Posterior Decompression, DIAM Spinal Stabilization, Fusion; Procedure · Device
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 35 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 9
States / cities: Fremont, California • Jacksonville, Florida • Melbourne, Florida + 6 more

Conditions: Lead Extraction Procedures
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Mitral Regurgitation
Interventions: MR-ace Implant and Delivery System; Device
Lead sponsor: Polares Medical SA; Industry
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 3
States / cities: Atlanta, Georgia • The Bronx, New York • Cincinnati, Ohio

Conditions: Chronic Heart Failure
Interventions: HeartWare® VAS (HVAD), Control LVAD; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 47
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 37 more

Conditions: TTR Cardiac Amyloidosis
Interventions: Biotronik Biomonitor 3 implant of device, Biotronik Biomonitor 3 explant of device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Atrial Fibrillation, Device Related Thrombus, Left Atrial Appendage Thrombosis, Watchman LAA Closure Device
Interventions: Dabigatran Etexilate Oral Capsule; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Spinal Cord Injuries, Stroke, Paralysis, Tetraplegia, Paraplegia
Interventions: IST (Implanted Stimulator-Telemeter); Device
Lead sponsor: Case Western Reserve University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injuries, Spinal Cord Diseases, Paralysis, Central Nervous System Diseases, Cough
Interventions: Spinal Cord Stimulation, Expiratory Muscle Stimulator; Procedure · Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Presence of High Intracranial Pressure
Interventions: EVD; Device
Lead sponsor: HeadSense Medical; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Miami, Florida • Baltimore, Maryland • Cleveland, Ohio

Conditions: Overactive Bladder
Interventions: Retrospective chart review; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Orange, California

Conditions: Prostate Cancer
Interventions: surgery, radiation; Procedure · Radiation
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: Up to 75 Years · Male only
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 30
States / cities: Little Rock, Arkansas • San Francisco, California • Washington D.C., District of Columbia + 26 more

Conditions: Osteoarthritis, Knee
Interventions: AposHealth, Total Knee Replacement (TKR); Device · Procedure
Lead sponsor: Geisinger Clinic; Other
Eligibility: 45 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Danville, Pennsylvania • Wilkes-Barre, Pennsylvania

Conditions: HTN-Hypertension, Blood Pressure Management
Interventions: CSN electrode was implanted around tissue including CSN branches; Device
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prostate Cancer
Interventions: Medical Device Usage and Evaluation, CT simulation, Stereotactic body radiation therapy, Brachytherapy, Post-implant dosimetry scan; Device · Procedure · Radiation
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Feasibility Study of Auditory Brainstem Implant in Young Children

Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries

Effects of Stimulation Patterns of Deep Brain Stimulation

MDR - Comprehensive Primary Revision Stems PMCF

The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth

BlueSync Field Evaluation

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion

Pacemaker and Defibrillator Lead Extraction Registry

EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)

A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL)

Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).

Evaluation of an Advanced Lower Extremity Neuroprostheses

Sub-study to Spinal Cord Stimulation to Restore Cough

An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device

Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement

Direct Carotid Sinus Nerve Stimulation in Anesthetized Human Subjects

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer